Trial intelligence / Profile preview

Postoperative chemotherapy versus observation in node-negative stage I–II intermediate/high-risk endometrial cancer

2010-023081-52Phase 2Completed

Sponsor: Danish Gynecological Cancer Group
Start: Dec 2010
Modality: DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries: 1

Overview

Phase 2, randomised trial in endometrial cancer (EC) comparing Adjuvant paclitaxel + carboplatin with Observation (2 arms). Primary endpoint: overall survival in the subgroup of endometrioid adenocarcinoma. Started Dec 2010; status: completed.

Drugs

paclitaxelcarboplatin

Conditions

endometrial cancer (EC)

Beyond the preview

Go deeper on 2010-023081-52.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-023081-52.